Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Interest Expenses (2016 - 2025)

Historic Interest Expenses for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $37000.0.

  • International Stem Cell's Interest Expenses rose 571.43% to $37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $155000.0, marking a year-over-year increase of 1071.43%. This contributed to the annual value of $145000.0 for FY2024, which is 431.65% up from last year.
  • Per International Stem Cell's latest filing, its Interest Expenses stood at $37000.0 for Q3 2025, which was up 571.43% from $38000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Interest Expenses peaked at $41000.0 during Q4 2021, and registered a low of $18000.0 during Q3 2021.
  • Over the past 5 years, International Stem Cell's median Interest Expenses value was $35000.0 (recorded in 2022), while the average stood at $35000.0.
  • As far as peak fluctuations go, International Stem Cell's Interest Expenses crashed by 3571.43% in 2021, and later surged by 9444.44% in 2022.
  • Over the past 5 years, International Stem Cell's Interest Expenses (Quarter) stood at $41000.0 in 2021, then dropped by 19.51% to $33000.0 in 2022, then grew by 3.03% to $34000.0 in 2023, then increased by 14.71% to $39000.0 in 2024, then dropped by 5.13% to $37000.0 in 2025.
  • Its Interest Expenses stands at $37000.0 for Q3 2025, versus $38000.0 for Q2 2025 and $41000.0 for Q1 2025.